Compare IDYA & ANDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IDYA | ANDE |
|---|---|---|
| Founded | 2015 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Farming/Seeds/Milling |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.3B |
| IPO Year | 2019 | 2005 |
| Metric | IDYA | ANDE |
|---|---|---|
| Price | $31.94 | $65.19 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 16 | 2 |
| Target Price | $51.21 | ★ $75.00 |
| AVG Volume (30 Days) | ★ 757.3K | 266.3K |
| Earning Date | 05-19-2026 | 05-20-2026 |
| Dividend Yield | N/A | ★ 1.24% |
| EPS Growth | ★ 61.90 | 12.93 |
| EPS | N/A | ★ 0.82 |
| Revenue | $218,710,000.00 | ★ $11,008,928,000.00 |
| Revenue This Year | N/A | $13.28 |
| Revenue Next Year | $97.58 | $5.76 |
| P/E Ratio | ★ N/A | $79.09 |
| Revenue Growth | ★ 3024.43 | N/A |
| 52 Week Low | $13.45 | $31.03 |
| 52 Week High | $39.28 | $70.06 |
| Indicator | IDYA | ANDE |
|---|---|---|
| Relative Strength Index (RSI) | 45.48 | 56.89 |
| Support Level | $29.15 | $62.90 |
| Resistance Level | $33.64 | $70.06 |
| Average True Range (ATR) | 1.47 | 2.23 |
| MACD | 0.10 | -0.63 |
| Stochastic Oscillator | 59.47 | 31.98 |
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
Andersons Inc is a diversified company with its main focus in the agriculture sector. Its operations are segmented into Trade, Renewables, and Nutrient & Industrial. The Trade segment, which generates the majority of the revenue, is engaged in the movement of physical commodities such as whole grains, grain products, feed ingredients, and domestic fuel products, among other agricultural commodities. Geographically, the company generates the majority of its revenue from the United States and the rest from Canada, Mexico, Egypt, Switzerland, and other markets.